🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Love this team! DCI Center for Prostate & Urologic Cancers Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) Dan George Landon C. Brown Hannah Dzimitrowicz McManus Jason Zhu #ASCO23 what a busy day!

The best kind of day in #oncology — spend it with your tribe. Loved seeing Landon C. Brown Hannah Dzimitrowicz McManus Jason Zhu Chester Kao again ASCO #ASCO23

Microbiome metabolites associated with worse outcomes on immunotherapy in RCC pts. Thrilled to welcome Shahla Bari MD to DCI Center for Prostate & Urologic Cancers. Thanks Prostate Cancer Foundation for her #YoungInvestigatorAward

Always a pleasure chatting with Andrew Armstrong about how to improve care for our patients with #prostatecancer ! Check out this new podcast series discussing mHSPC.

Stefania Morganti, MD Nancy Lin, MD Dr Sarah Sammons Dana-Farber’s Breast Oncology Center Sara Tolaney G Curigliano MD PhD Paolo Tarantino ASCO Join us next week, January 23 as Hannah Dzimitrowicz McManus & Andrew Armstrong discuss updates on the use of PARP inhibitors + androgen receptor pathway inhibitors (ARPI) in #prostatecancer!

Tune in and bring your questions tonight! Very excited to chat all things parp/arpi and #prostatecancer with Andrew Armstrong Great way to start the week leading up to #GU24 ASCO ! #bestweekever

Awesome start to #GU24 sharing our clinical and implementation outcomes using pluvicto at DCI Center for Prostate & Urologic Cancers with rising ⭐️s Valeria Maldonado Grijalva and Marybeth Nedrud, connecting with forever mentor/friend Tian Zhang, MD, MHS, and team bonding thanks to the GOAT Dan George

Wondering what to offer your NEPC/small cell prostate cancer patient after platinum chemo? Clinical trials but also perhaps lurbinectedin! See DCI Center for Prostate & Urologic Cancers poster with Alan H Bryce showing activity. #GU2024

1/4 🚨 Time for a #TumorBoardTuesday extra! Andrew Armstrong discusses developments w PARPi from #GU24: - Sequence PARPi, vs w ARSI upfront? - Which mutations benefit most from PARPi? - Role for PARPi in castration sensitive #prostatecancer? Keep scrolling for 📽️ updates👇

At #AACR2024 ? Come check out our poster examining uptake of guideline concordant mHSPC care in IRONMAN Registry . Rapid uptake of changing therapies and 86% rate overall📈. Important to develop quality benchmarks to ensure #prostatecancer patients getting best therapies.

The #WomeninOncology networking center has a wonderful line up at #ASCO24! Privileged to join Katherine Van Loon, MD, MPH Suzanne Cole, MD, FACP, FASCO #JeannyArahonChing #TriciaKalwar on Combating the Saboteurs panel Join: 6/1 3:15-4pm in S502 & for all the programming & connections! conferences.asco.org/am/womens-netw…

Bittersweet last clinic day UNC Hospitals after 10 years UNC-Chapel Hill between college, residency, and fellowship. Seems like the right time to announce I’ll be joining DCI Center for Prostate & Urologic Cancers as faculty in July. Excited to get started! Dan George Andrew Armstrong Matt Labriola Hannah Dzimitrowicz McManus

Large UK Biobank study confirmed many heritable gene-cancer associations. Shevach and Hannah Dzimitrowicz McManus explain how the new data underlines that ppl w many cancers types & THEIR FAMILIES should get genetic screening & that we must stop disparities in testing. Duke Cancer Kathleen Cooney

Thank you World GU Conference for the opportunity to share our work in IRONMAN Registry demonstrating the ability to adapt guideline concordant care for #prostatecancer in the real world. Fantastic conference for learning, networking, and fun! IDEOlogy Health

Excited to share our new review on Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journey. Andrew Armstrong Alicia Morgans, MD, MPH Tanya Dorff Oliver Sartor neal shore Prostate Cancer and Prostatic Diseases rdcu.be/dXjgg

Fantastic recognition for Dan George DCI Center for Prostate & Urologic Cancers — recipient of this year’s Vogelzang humanitarian award!! Matt Labriola Hannah Dzimitrowicz McManus Michael Harrison Andrew Armstrong please celebrate him when he gets home!

Check out our podcast reachmd.com/programs/proje… on treatment sequencing in mCRPC with Hannah Dzimitrowicz McManus based on this Prostate Cancer and Prostatic Diseases article: pubmed.ncbi.nlm.nih.gov/39420184/ DCI Center for Prostate & Urologic Cancers

Come check out our latest work in IRONMAN Registry evaluating PSA nadir and relationship to disease relapse in mHSPC at poster B11 #GU25

Great job Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) discussing the moons of Jupiter and new advances in kidney cancer at #GU25 ASCO !

Federal #kidneycancer research funding drops from $50 million to ZERO after 57% cut to CDMRP. All but 12 of the 35 disease research programs saw funding eliminated for 2025, including the Kidney Cancer Research Program. More about the impact on our blog. bit.ly/4hoXnCq